Breakthrough trial aims to save babies from Malaria's hidden threat

NCT ID NCT04336189

Summary

This large study tested whether combining two malaria prevention drugs works better than using either drug alone to protect pregnant women and their babies. Researchers enrolled 2,757 HIV-negative pregnant women in Uganda and randomly assigned them to receive different monthly preventive treatments. The goal was to find the safest, most effective approach to prevent malaria infections and reduce risks like low birth weight, premature birth, and infant death.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Infectious Diseases Research Collaboration Clinic - Masafu Hospital

    Masafu, Busia, Uganda

Conditions

Explore the condition pages connected to this study.